← Back to guidelines
Psychiatry18 papers

Infection after injection

Last edited: 4/10/2026

Overview

Infection after injection refers to the risk of acquiring infections, particularly HIV, following nonoccupational exposure to contaminated needles or other percutaneous injuries. Postexposure prophylaxis (nPEP) is a strategy to prevent transmission of such infections.

Diagnosis

  • HIV testing (rapid or laboratory-based antigen/antibody combination) is recommended before initiating nPEP 1.
  • Management

  • Nonoccupational postexposure prophylaxis (nPEP) for HIV is recommended for exposures presenting a substantial risk for HIV transmission when the source has HIV without sustained viral suppression or unknown viral suppression status 1.
  • Initiate the first dose of nPEP as soon as possible, ideally within 24 hours, but no later than 72 hours after exposure 1.
  • Do not delay the initial nPEP dose due to pending laboratory test results 1.
  • The recommended duration of nPEP is 28 days 1.
  • Newer antiretroviral agents and updated nPEP indication considerations are included in current guidelines 1.
  • Key Recommendations

  • Nonoccupational postexposure prophylaxis (nPEP) for HIV is recommended for exposures with a substantial risk for HIV transmission and an HIV-positive source with unknown or unsuppressed viral load 1. (Evidence: Strong)
  • Initiate nPEP as soon as possible, ideally within 24 hours, and no later than 72 hours after exposure 1. (Evidence: Strong)
  • The recommended duration for nPEP is 28 days 1. (Evidence: Strong)
  • References

    1 Tanner MR, O'Shea JG, Byrd KM, Johnston M, Dumitru GG, Le JN et al.. Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV - CDC Recommendations, United States, 2025. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 2025. link

    Original source

    1. [1]
      Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV - CDC Recommendations, United States, 2025.Tanner MR, O'Shea JG, Byrd KM, Johnston M, Dumitru GG, Le JN et al. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports (2025)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG